Randomized Controlled Trial of Etodolac versus Combination of Etodolac and Eperisone in Patients of Knee Osteoarthritis

Table 2

Demographic and baseline clinical characteristics of 60 patients.

Characteristics	Etodolac group; (𝑛=30)	Etodolac + eperisone group; (𝑛=30)	𝑃 value; (*NS)
Gender
Male	8	11	0.198*
Female	22	19
Age in years	51.33±8.14	51.87±6.88	0.594*
Weight in kg	63.07±5.84	61.93±5.44	0.125*
Disease duration (years)	2.19±1.15	1.84±1.23	0.144*
Pain (VAS) score	7.43±0.63	7.37±0.61	0.440*
Joint tenderness score	2.63±0.49	2.50±0.51	0.163*
Swelling score	1.87±0.68	1.90±0.84	0.844*
Erythema score	1.80±0.66	1.87±0.82	0.453*
Pain on movement score	2.43±0.57	2.37±0.56	0.401*
Functional capacity score	2.57±0.57	2.43±0.50	0.163*
Overall arthritic condition score	3.53±0.57	3.47±0.51	0.384*

Data are in mean ± S.D.